Composite MR contrast agents for conditional cell‐labeling

Gadolinium‐chelates (Gd‐DTPA) and superparamagnetic particles of iron oxide (SPIO) are two commonly used MR contrast agents that exhibit inherently different relaxation properties. These two agents have been used to label cells ex‐vivo to generate signal contrast with respect to background tissue when introduced to a tissue‐of‐interest. Assuming minimal mutual interaction between these two agents, we were motivated to investigate the creation of composite relaxation properties by mixing the two in aqueous solutions for conditioning cell labeling. Concentration‐dependent relaxivity coefficients were first obtained from each contrast agent, independently, in saline solution at 3 Tesla. These coefficients were then used to predict both the R1 and R2 relaxation rates of a composite contrast agent using a linear model combining the effects of both contrast media. The predicted relaxation rates were experimentally confirmed from 25 composite solutions (combinations of SPIO‐concentration ranging from 0 to 1 μg/mL and Gd‐DTPA‐concentration ranging from 0 to 0.20 mM). We show that the combination of SPIO and Gd‐DTPA in an aqueous solution exhibits unique and predictable relaxivity properties that are unattainable via the individual use of either agent. The method may be applied to create “user‐tunable” contrast conditions for the visualization of magnetically labeled cells in the context of cell replacement therapy. © 2008 Wiley Periodicals, Inc. Int J Imaging Syst Technol, 18, 79–84, 2008

[1]  John M Pauly,et al.  Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles , 2005, Magnetic resonance in medicine.

[2]  Roger A. Barker,et al.  Cell Therapy in Parkinson’s Disease , 2009 .

[3]  S. Kaul,et al.  Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression , 2005, Circulation.

[4]  M. Does,et al.  Aqueous urea as a model system for bi-exponential relaxation , 2007, Magnetic Resonance Materials in Physics, Biology and Medicine.

[5]  B. Rutt,et al.  Application of the static dephasing regime theory to superparamagnetic iron‐oxide loaded cells , 2002, Magnetic resonance in medicine.

[6]  M. Filippi,et al.  Inflammation in multiple sclerosis: the good, the bad, and the complex , 2002, The Lancet Neurology.

[7]  R. Weissleder,et al.  Fluorescent nanoparticle uptake for brain tumor visualization. , 2006, Neoplasia.

[8]  S. Yoo,et al.  Independent Component Analysis for the Examination of Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging Data: Preliminary Study , 2002, Investigative radiology.

[9]  M. Wendland,et al.  T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning , 2006, European Radiology.

[10]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[11]  Gaby S Pell,et al.  Optimized clinical T2 relaxometry with a standard CPMG sequence , 2006, Journal of magnetic resonance imaging : JMRI.

[12]  Craig H Meyer,et al.  Technology Insight: in vivo cell tracking by use of MRI , 2006, Nature Clinical Practice Cardiovascular Medicine.

[13]  Kathryn Sharer,et al.  In vivo detection of single cells by MRI , 2006, Magnetic resonance in medicine.

[14]  S. Holland,et al.  NMR relaxation times in the human brain at 3.0 tesla , 1999, Journal of magnetic resonance imaging : JMRI.

[15]  R. Kim,et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.

[16]  J. Pearlman,et al.  Novel double contrast MRI technique for intramyocardial detection of percutaneously transplanted autologous cells , 2004, Magnetic resonance in medicine.

[17]  Alan P Koretsky,et al.  MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Dewhirst,et al.  Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. , 2003, AJR. American journal of roentgenology.

[19]  J. Debatin,et al.  Detection of Atherosclerotic Plaque With Gadofluorine-Enhanced Magnetic Resonance Imaging , 2003, Circulation.

[20]  K. Eichler,et al.  Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. , 2002, Radiology.

[21]  J A Frank,et al.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  V. Fuster,et al.  MRI to detect atherosclerosis with gadolinium‐containing immunomicelles targeting the macrophage scavenger receptor , 2006, Magnetic resonance in medicine.

[23]  P. Foster,et al.  Cellular Imaging of Inflammation after Experimental Spinal Cord Injury , 2005, Molecular imaging.

[24]  C. Roy,et al.  Magnetic resonance lymphography , 2007, Current opinion in urology.

[25]  M. Kanematsu,et al.  Malignant hepatic tumor detection with ferumoxides‐enhanced MR imaging with a 1.5‐T system: Comparison of four imaging pulse sequences , 2001, Journal of magnetic resonance imaging : JMRI.

[26]  J. Pearlman,et al.  Early lung cancer detection based on registered perfusion MRI. , 2006, Oncology reports.

[27]  Bradley James Erickson,et al.  An algorithm for automatic segmentation and classification of magnetic resonance brain images , 2009, Journal of Digital Imaging.

[28]  D. Rosenbaum,et al.  Cell therapy for stroke , 2004 .

[29]  R. Meneghini,et al.  Iron and its sensitive balance in the cell. , 2001, Mutation research.

[30]  Mathias Hoehn,et al.  Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat , 2002, Proceedings of the National Academy of Sciences of the United States of America.